loading page

SARS-CoV-2 Omicron variants BA.4 and BA.5 dominated the fifth COVID-19 epidemiological wave in Mexico
  • +12
  • Blanca Taboada,
  • Selene Zarate ,
  • Rodrigo García-López,
  • José Muñoz-Medina,
  • Bruno Gómez-Gil,
  • Alfredo Herrera-Estrella,
  • Alejandro Sanchez-Flores,
  • Angel Gustavo Salas Lais,
  • Benjamin Roche,
  • Gabriela Martínez-Morales,
  • Hermilo Domínguez Zárate,
  • Célida Duque Molina,
  • Ricardo Avilés Hernández,
  • Susana López,
  • Carlos F. Arias
Blanca Taboada
Universidad Nacional Autonoma de Mexico Instituto de Biotecnologia

Corresponding Author:[email protected]

Author Profile
Selene Zarate
Universidad Autonoma de la Ciudad de Mexico - Plantel Del Valle
Author Profile
Rodrigo García-López
Universidad Nacional Autonoma de Mexico Instituto de Biotecnologia
Author Profile
José Muñoz-Medina
Instituto Mexicano del Seguro Social
Author Profile
Bruno Gómez-Gil
Centro de Investigacion en Alimentacion y Desarrollo AC
Author Profile
Alfredo Herrera-Estrella
Laboratorio Nacional de Genomica para la Biodiversidad
Author Profile
Alejandro Sanchez-Flores
Universidad Nacional Autonoma de Mexico Instituto de Biotecnologia
Author Profile
Angel Gustavo Salas Lais
Instituto Mexicano del Seguro Social
Author Profile
Benjamin Roche
MiVEGEC
Author Profile
Gabriela Martínez-Morales
Instituto Mexicano del Seguro Social
Author Profile
Hermilo Domínguez Zárate
Instituto Mexicano del Seguro Social
Author Profile
Célida Duque Molina
Instituto Mexicano del Seguro Social
Author Profile
Ricardo Avilés Hernández
Instituto Mexicano del Seguro Social
Author Profile
Susana López
Universidad Nacional Autonoma de Mexico Instituto de Biotecnologia
Author Profile
Carlos F. Arias
Universidad Nacional Autonoma de Mexico Instituto de Biotecnologia
Author Profile

Abstract

In Mexico, the BA.4 and BA.5 Omicron variants dominated the fifth epidemic wave (summer 2022), superseding BA.2, which had circulated during the inter-wave period. The present study uses genome sequencing and statistical and phylogenetic analyses to examine these variants’ prevalence, distribution, and genetic diversity in Mexico from April to August 2022. Over 35% of the sequenced genomes in this period corresponded to the BA.2 variant, 8% to the BA.4, and 56% to the BA.5 variant. Multiple subvariants were identified, but only BA.2.9, BA.2.12.1, BA.5.1, BA.5.2, BA.5.2.1, and BA.4.1 circulated throughout the fifth wave across the entire country, not forming geographical clusters. Contrastingly, other subvariants exhibited a geographically restricted distribution, most notably in the Southeast region, which showed a distinct subvariant dynamic. This study supports previous results showing that this region may be a major entry point and may have contributed to the introduction and evolution of novel variants in Mexico. Furthermore, a differential distribution was observed for certain subvariants among specific States throughout time, which may have contributed to the overall increased diversity observed during this wave compared to the previous one. This study highlights the importance of sustaining genomic surveillance to identify novel variants that may impact public health.